PMV Pharmaceuticals, Inc.
Developing small molecule therapies targeting p53 mutations to treat cancer.
PMVP | NDAQ
Overview
Corporate Details
- ISIN(s):
- US69353Y1038
- LEI:
- Country:
- United States of America
- Address:
- 400 ALEXANDER PARK DRIVE, 8540 PRINCETON
- Website:
- https://www.pmvpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PMV Pharmaceuticals, Inc. is a clinical-stage precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies for cancer. The company's research is dedicated to targeting mutations in the p53 tumor suppressor protein, which are found in approximately half of all human cancers. PMV's unique therapeutic approach aims to restore the normal tumor-suppressing function of mutated p53 by structurally correcting the protein's geometry. Its pipeline consists of first-in-class p53 regulators designed to provide new treatment options for patients whose tumors harbor these specific mutations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PMV Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PMV Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PMV Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
